Sanofi suffers major setback in development of a Covid-19 vaccine
Your bookmark folders are private.
No folders match. Try another name or add a new folder.
Sanofi had previously projected it could produce 100 million doses of vaccine in 2020, and 1 billion doses in 2021.
The news is not just disappointing for Sanofi and its development partner, GlaxoSmithKline, which is providing an adjuvant used in the vaccine...
No comments yet.
Placed in
Keep exploring
More to explore from shared collections and topics.
Contribute to BackpackerU Resources
Sign in to suggest resources and start organizing your own travel-learning library.
BackpackerU Resources uses cookies from Google to deliver and enhance its services and to analyze traffic.
No comments yet.